Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dermtech Inc
(NQ:
DMTK
)
0.6247
+0.0047 (+0.76%)
Streaming Delayed Price
Updated: 3:58 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dermtech Inc
< Previous
1
2
3
4
Next >
Looking Into DermTech's Return On Capital Employed
May 13, 2022
Benzinga Pro data, DermTech (NASDAQ:DMTK) reported Q1 sales of $3.72 million. Earnings fell to a loss of $30.11 million, resulting in a 15.56% decrease from last quarter.
Via
Benzinga
DermTech: Q1 Earnings Insights
May 03, 2022
DermTech (NASDAQ:DMTK) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech missed estimated earnings by...
Via
Benzinga
DermTech's Earnings Outlook
May 02, 2022
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that DermTech will...
Via
Benzinga
DermTech: Q4 Earnings Insights
March 01, 2022
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech...
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Earnings Outlook For DermTech
February 28, 2022
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
Recap: DermTech Q2 Earnings
August 04, 2021
Shares of DermTech (NASDAQ:DMTK) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 1.72% over the past year to ($0...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
This Is the Main Problem With DermTech's Q3 Results
November 20, 2021
Nothing major changed for the skin genomics company in Q3.
Via
The Motley Fool
Better Buy: 10x Genomics vs. DermTech
November 11, 2021
Both companies offer disruptive new solutions in their niches of the healthcare space.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 10, 2021
Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 10, 2021
Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday.
Via
InvestorPlace
30 Stocks Moving in Wednesday's Pre-Market Session
November 10, 2021
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
DermTech's Return On Capital Employed Overview
November 09, 2021
DermTech (NASDAQ:DMTK) brought in sales totaling $3.12 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.03%, resulting in a loss of $17...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
3 Things About DermTech That Smart Investors Know
October 20, 2021
These three facts can help you determine whether you want in on this fast-growing company.
Via
The Motley Fool
How DermTech Could Change Skin Cancer Testing -- Or Fizzle Out
September 14, 2021
DermTech's innovative skin treatment is making it easier and cheaper to test for skin cancer, causing the business to grow. Fast.
Via
The Motley Fool
Should Investors Be Concerned About DermTech?
September 12, 2021
Be concerned? No. Be patient? Yes.
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
September 12, 2021
Their growth prospects are massive.
Via
The Motley Fool
Looking into DermTech's Return on Capital Employed
August 20, 2021
Pulled from Benzinga Pro data DermTech (NASDAQ:DMTK) reported Q2 sales of $3.12 million. Earnings fell to a loss of $17.31 million, resulting in a 29.03% decrease from last...
Via
Benzinga
Why Shares of DermTech Dropped 19% in July
August 09, 2021
The company's noninvasive skin genomics platform has great potential, but its losses have made investors wary.
Via
The Motley Fool
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 04, 2021
Gainers Scopus BioPharma (NASDAQ:SCPS) s...
Via
Benzinga
This Medical Device Company Is Changing the Game in Skin Cancer
July 18, 2021
And it's on sale right now.
Via
The Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.